Based on these backgrounds, the molecular mechanisms of the drug resistance in lymphoma cells have been intensively investigated for the development of more effective treatments for canine lymphoma, and most studies have focused on the overexpression of drug transporters such as P-glycoprotein (P-gp). This evidence concerns the gene PGP and lymphoma.